toxylact: a06ax01 glycerol

The first professional lActological database in the word


Glycerol (A06AX01) is a locally acting rectal laxative used for short‑term symptomatic treatment of constipation and is considered compatible with breastfeeding because of minimal systemic absorption and negligible expected transfer into breast milk.atcddd.fhi+7

Pharmacotherapeutic group and mechanism

Glycerol is classified in ATC subgroup A06AX “Other drugs for constipation” with specific code A06AX01.atcddd.fhi+2
It is typically formulated as rectal suppositories, where it acts as an osmotic dehydrating agent, increasing water content and osmotic pressure in the rectum, softening stool and stimulating local reflexes that promote defecation.pmc.ncbi.nlm.nih+2

Indications, dosage and administration

Clinical use of glycerol suppositories is mainly for short‑term, symptomatic relief of occasional constipation, particularly when a rapid local effect is desired (e.g. postoperative or in patients who cannot tolerate oral laxatives).clevelandclinic+2
The ATC/DDD Index lists A06AX01 as glycerol but does not define a systemic DDD, reflecting its use as single rectal doses rather than chronic daily therapy.atcddd.fhi
Typical adult regimens involve one suppository administered rectally as needed, with instructions emphasizing correct rectal insertion technique, limited duration of use and avoidance of excessive frequency to prevent local irritation or dependence on rectal stimulation.clevelandclinic+2

General toxicological profile

Because glycerol suppositories act locally in the rectum, systemic exposure is minimal and systemic toxicity is rare at recommended doses.clevelandclinic+2
Common adverse effects include mild local irritation, rectal discomfort, urgency and, occasionally, cramping; improper insertion or frequent use may cause anal soreness or, rarely, mechanical trauma.clevelandclinic+1
Systemic adverse events related to osmotic effects (e.g. dehydration or electrolyte imbalance) are theoretically possible with very frequent high‑dose use, but are unusual given the localized action and short‑term indication. Glycerol has a long history of use as a safe laxative in adults and children, including neonatal practice for meconium passage, further supporting its benign toxicological profile.pmc.ncbi.nlm.nih+2

Lactation‑toxicology considerations

Specialist breastfeeding guidance states that any laxative can generally be used during breastfeeding because most are either not absorbed or are minimally absorbed from the gastrointestinal tract, resulting in low or negligible levels in breast milk.sps+1
For glycerol specifically, expert sources note that glycerol suppositories can be used during breastfeeding and that no specific infant monitoring is usually required, beyond routine observation of feeding, stool pattern and weight gain.sps+1

A UK perinatal medicines guide reports that there are no human data on exogenous glycerol use in breastfeeding women but concludes that it is unlikely to be hazardous, as most glycerol is metabolized in the gut when taken orally and rectal administration yields minimal systemic exposure. This assessment is consistent with the molecule’s endogenous presence in human metabolism and its widespread medicinal use. Because rectal glycerol acts locally with minimal absorption, transfer into breast milk is expected to be negligible, and even any small absorbed amounts would contribute insignificantly to maternal glycerol levels compared with endogenous production.midlandsmedicines

Overall, glycerol (A06AX01) is regarded as compatible with breastfeeding, suitable as a short‑course rectal laxative in nursing mothers when lifestyle measures and oral laxatives are not sufficient or appropriate, with no need to interrupt breastfeeding.sps+2

Clinical use in breastfeeding women

In breastfeeding women, constipation management should start with lifestyle interventions such as increased dietary fibre, fluid intake and physical activity, which also help maintain milk supply.sps+1
If pharmacological treatment is needed, glycerol suppositories represent a convenient short‑term option with rapid local action and minimal systemic exposure, and can be used without routine infant monitoring or breastfeeding interruption.clevelandclinic+3

Clinicians should advise nursing mothers to use the lowest effective dose for the shortest duration and to avoid habitual use, reserving glycerol for episodes where a quick rectal effect is clinically desirable. If constipation persists, evaluation for underlying causes and consideration of alternative laxatives with established lactation safety profiles (bulk‑forming or osmotic agents) are appropriate, following general guidelines that prioritize clinical indications and maternal health while treating suitability in breastfeeding as a secondary but important consideration.sps+1


Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.